Osmotica Pharmaceutical Corp. Company Profile

Osmotica Pharmaceutical is a global specialty pharmaceutical company with a proven history of developing commercially successful pharmaceutical products. The company uses its proprietary osmotic technology platform and with strategic partners develops and commercializes high quality pharmaceutical products. In addition to the products currently on the market, the company’s pipeline includes several neurology-based therapeutic drugs.
News Articles
Osmotica Pharmaceutical Corp. Announces the Appointment of Darren Alkins as Executive Vice President
Osmotica Pharmaceutical Corp. today announced the appointment of Darren Alkins as Executive Vice President. Forrest Waldon, CEO of Osmotica Pharmaceutical stated, “We are please...
India's Panacea, Osmotica Of U.S. Join On 18 Drugs For Global Market
Panacea Biotec of India and Osmotica Pharmaceutical of the U.S. have agreed to joint development of 18 drugs for the global market, each sharing the cost and profits.
Osmotica Pharmaceutical Announces Initiation of Phase III Studies with Arbaclofen ER Tablets
Osmotica Pharmaceutical announced today that recruitment has begun for a Phase 3 clinical trial designed to assess the safety and efficacy of Arbaclofen Extended Release Tablets i...
Osmotica Pharmaceutical management update
Osmotica Pharmaceutical, Panacea Biotec deal
Osmotica Pharmaceutical and Panacea Biotec Announce Strategic Alliance Agreement
Osmotica Pharmaceutical Corp. today announced the execution of a strategic alliance agreement between Panacea Biotec and Osmotica Kft. for the research, development and commercial...
Osmotica Pharmaceutical Corp. today announced the appointment of Dr. Praveen Tyle as Executive Vice President and Chief Scientific Officer. He also serves as the Managing Director...
The Board of Osmotica Pharmaceutical today announced the appointment of Dr. Praveen Tyle as President and Chief Executive Officer. He was also elected as a member of the Companyâ€...
Drugs and Medications
None
PubMed Articles
Thraustochytrids Can Be Grown in Low-Salt Media Without Affecting PUFA Production.
Marine microheterotrophs thraustochytrids are emerging as a potential source for commercial production of polyunsaturated fatty acids (PUFA) that have nutritional and pharmacological values. With pros...
Clinical Trials
None
Companies
Osmotica Pharmaceutical is a global specialty pharmaceutical company with a proven history of developing commercially successful pharmaceutical products. The company uses its prop...
More Information about "Osmotica Pharmaceutical Corp." on BioPortfolio
We have published hundreds of Osmotica Pharmaceutical Corp. news stories on BioPortfolio along with dozens of Osmotica Pharmaceutical Corp. Clinical Trials and PubMed Articles about Osmotica Pharmaceutical Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Osmotica Pharmaceutical Corp. Companies in our database. You can also find out about relevant Osmotica Pharmaceutical Corp. Drugs and Medications on this site too.